Becton, Dickinson Offers Dividend And Growth Potential
By Efficient Alpha:
By Carson Ko
Becton, Dickinson and Company (BDX) is a global medical technology manufacturer. BDX develops, manufactures and sells medical devices such as needles, syringes, prefillable drug delivery system, specimen and blood collection systems as well as analysis and research machinery for pharmaceutical and biotechnology companies.Becton, Dickinson and Company’s clients range from consumers, retailers, blood banks, clinical laboratories, hospitals, and Governmental and nonprofit public health agencies. BDX’s major competitors include Baxter (BAX), Covidien (COV), Boston Scientific (BSX), C.R. Bard (BCR), Hologic (HOLX), Gen-Probe (GPRO) and Retractable Tech (RVP). Below is a chart (click to enlarge) showing the trailing twelve months revenue comparison among BDX’s competitors. Although BDX is not the biggest fish in the pond, with 17% of the industry, it has a long history within the segment and has been able to maintain consistent revenue growth close to 10% annually.
Diversified Revenue Stream:
BDX’s operations are separated intoComplete Story »